ImmunityBio (IBRX) Asset Utilization Ratio (2015 - 2026)
ImmunityBio (IBRX) reported Asset Utilization Ratio of 0.25 for Q1 2026, up 169.96% year-over-year from 0.09 in Q1 2025, and up 10.61% quarter-over-quarter from 0.22 in Q4 2025.
ImmunityBio (IBRX) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 12 years of Asset Utilization Ratio data on file, last reported at 0.25 in Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 0.25, up 169.96% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.25 (up 169.96% YoY), and the FY2025 annual result was 0.26, up 670.53% from the prior year.
- Asset Utilization Ratio grew to 0.25 in Q1 2026 per IBRX's latest filing, from 0.22 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.25 in Q1 2026 and troughed at 0.0 in Q1 2024.
- A 5-year average of 0.06 and a median of 0.0 in 2022 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio tumbled 75.45% in 2022, then surged 13527.09% in 2025.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.0 in 2022, then surged by 97.87% to 0.0 in 2023, then jumped by 2871.13% to 0.04 in 2024, then jumped by 462.57% to 0.22 in 2025, then advanced by 10.61% to 0.25 in 2026.
- Business Quant data shows IBRX's Asset Utilization Ratio at 0.25 in Q1 2026, 0.22 in Q4 2025, and 0.18 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | ImmunityBio | 7.55 Bn | 7.17 Bn | 43.97 Mn | 0.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.25 |
| Dec 31, 2025 | 0.22 |
| Sep 30, 2025 | 0.18 |
| Jun 30, 2025 | 0.16 |
| Mar 31, 2025 | 0.09 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |